Hyper Corporation Inc. (KOSDAQ: 065650)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,218.00
+7.00 (0.58%)
Oct 11, 2024, 9:00 AM KST

Hyper Corporation Company Description

Hyper Corporation Inc., a clinical stage biopharmaceutical company, focuses on the development of Alzheimer's disease (AD) and neuropathic pain treatments, and AD diagnostics.

Its products under development include TRPV1 Antagonist and TRPV1 Agonist for neuropathic pain; and anti-oligomerization of beta-amyloid, receptor for advanced glycation endproduct modulator, and early diagnosis kits for AD.

The company wholesales and retails electronic devices, small home appliances, TVs, routers, and PC peripherals, such as gaming monitors, mouse, and wheels; keyboards; headsets; webcams; and sound bars, as well as provides online contents.

In addition, it manufactures and supplies frozen and room temperature convenience food products, such as frozen sticky rice and fish cakes, tteokbokki sauce, and raw materials for sauce under the Memories of Elementary School Tteokbokki, Newtro, and K-TOWN brands.

The company was formerly known as Medifron DBT Co., Ltd. and changed its name to Hyper Corporation Inc. in March 2024.

Hyper Corporation Inc. was founded in 1997 and is headquartered in Seoul, South Korea.

Hyper Corporation Inc.
Country South Korea
Founded 1997
Industry Computer Programming, Data Processing, And Other Computer Related Services
Employees 33

Contact Details

Address:
Cykan Holdings Tower
Seoul
South Korea
Website hyper-corp.com

Stock Details

Ticker Symbol 065650
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 7370